Lucid Diagnostics Inc. (LUCD)
Data as of , from SEC Form 4 filings.
See up to 3 months of LUCD. The 7-day demo opens the 1M and 3M ranges and puts LUCD on your watchlist.
Start 7-day demoLatest LUCD insider trades
About Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
- NEW YORK, NY
- 82
- 2021
- XNAS
LUCD Form 4 activity by transaction type, last 90 days
No Form 4 activity for LUCD in the last 90 days.
LUCD insider transactions (Form 4)
1414 Form 4 filings on record, the earliest from Aug 22, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dennis Matheis - Director | Open-market purchase | Common Stock | 245,000 | $1.00 footnote F1 | $245K | |
| ||||||
| Lishan Aklog - Officer | Grant or award | Common Stock | 2,170,000 footnote F1 | $0.00 | - | |
| ||||||
| Dennis Matheis - Director | Grant or award | Common Stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| Debra White - Director | Grant or award | Common Stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| Ronald M. Sparks - Director | Grant or award | Common stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| Jacque J. Sokolov - Director | Grant or award | Common Stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
 John R. Palumbo - Director | Grant or award | Common Stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| Stanley Lapidus - Director | Grant or award | Common Stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| James L. Cox - Director | Grant or award | Common Stock | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| Dennis M. McGrath - Officer | Grant or award | Common stock | 470,000 footnote F1 | $0.00 | - | |
| ||||||
 Shaun O'Neil - Officer | Grant or award | Common stock | 620,000 footnote F1 | $0.00 | - | |
| ||||||
| Michael Adam Gordon - Officer | Grant or award | Common stock | 300,000 footnote F1 | $0.00 | - | |
| ||||||
| John R. Palumbo - Director | Grant or award | Employee stock option (right to buy) | 215,000 | $0.00 | - | |
| Dennis Matheis - Director | Open-market purchase | Common Stock | 100,000 | $1.02 | $102K | |
Item 7.01, 9.01
Item 2.02, 7.01, 9.01
Item 5.03, 5.07, 9.01
Item 2.02, 7.01, 9.01
LUCD insider trading FAQ
What is the latest insider trade for LUCD?
Lucid Diagnostics Inc. (LUCD) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-21. The full record for LUCD runs to 14 Form 4 filings, the earliest from 2025-08-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LUCD stock?
No insider purchases of LUCD were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling LUCD stock?
No insider sales of LUCD were filed in the last 90 days.
Where can I see LUCD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LUCD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Dennis Matheis view on EDGAR
- - Lishan Aklog view on EDGAR
- - Dennis Matheis view on EDGAR
- - Debra White view on EDGAR
- - Ronald M. Sparks view on EDGAR
- - Jacque J. Sokolov view on EDGAR
- - John R. Palumbo view on EDGAR
- - Stanley Lapidus view on EDGAR
- - James L. Cox view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LUCD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LUCD with a 7-day demo
- LUCD on your watchlist
- Every LUCD Form 4 filing on record
- Up to 3 months of LUCD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
